Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells

Dustin J. Maxwell, Jesper Bonde, David A. Hess, Sarah A. Hohm, Ryan Lahey, Ping Zhou, Michael H. Creer, David Piwnica-Worms, Jan Nolta

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The use of nanometer-sized iron oxide particles combined with molecular imaging techniques enables dynamic studies of homing and trafficking of human hematopoietic stem cells (HSC). Identifying clinically applicable strategies for loading nanoparticles into primitive HSC requires strictly defined culture conditions to maintain viability without inducing terminal differentiation. In the current study, fluorescent molecules were covalently linked to dextran-coated iron oxide nanoparticles (Feridex) to characterize human HSC labeling to monitor the engraftment process. Conjugating fluorophores to the dextran coat for fluorescence-activated cell sorting purification eliminated spurious signals from nonsequestered nanoparticle contaminants. A short-term defined incubation strategy was developed that allowed efficient labeling of both quiescent and cycling HSC, with no discernable toxicity in vitro or in vivo. Transplantation of purified primary human cord blood lineage-depleted and CD34+ cells into immunodeficient mice allowed detection of labeled human HSC in the recipient bones. Flow cytometry was used to precisely quantitate the cell populations that had sequestered the nanoparticles and to follow their fate post-transplantation. Flow cytometry endpoint analysis confirmed the presence of nanoparticle-labeled human stem cells in the marrow. The use of fluorophore-labeled iron oxide nanoparticles for fluorescence imaging in combination with flow cytometry allows evaluation of labeling efficiencies and homing capabilities of defined human HSC subsets.

Original languageEnglish (US)
Pages (from-to)517-524
Number of pages8
JournalStem Cells
Volume26
Issue number2
DOIs
StatePublished - Feb 2008

Fingerprint

Hematopoietic Stem Cells
Nanoparticles
Flow Cytometry
Dextrans
Human Trafficking
Transplantation
Molecular Imaging
Optical Imaging
Fetal Blood
ferric oxide
Stem Cells
Bone Marrow
Bone and Bones
Population

Keywords

  • Feridex
  • Hematopoiesis
  • Human stem cells
  • Immune-deficient mice
  • Iron oxide
  • Nanoparticle
  • Transplantation

ASJC Scopus subject areas

  • Cell Biology

Cite this

Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. / Maxwell, Dustin J.; Bonde, Jesper; Hess, David A.; Hohm, Sarah A.; Lahey, Ryan; Zhou, Ping; Creer, Michael H.; Piwnica-Worms, David; Nolta, Jan.

In: Stem Cells, Vol. 26, No. 2, 02.2008, p. 517-524.

Research output: Contribution to journalArticle

Maxwell, Dustin J. ; Bonde, Jesper ; Hess, David A. ; Hohm, Sarah A. ; Lahey, Ryan ; Zhou, Ping ; Creer, Michael H. ; Piwnica-Worms, David ; Nolta, Jan. / Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. In: Stem Cells. 2008 ; Vol. 26, No. 2. pp. 517-524.
@article{8548b3935c874befab0a3fe3abd6f0f3,
title = "Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells",
abstract = "The use of nanometer-sized iron oxide particles combined with molecular imaging techniques enables dynamic studies of homing and trafficking of human hematopoietic stem cells (HSC). Identifying clinically applicable strategies for loading nanoparticles into primitive HSC requires strictly defined culture conditions to maintain viability without inducing terminal differentiation. In the current study, fluorescent molecules were covalently linked to dextran-coated iron oxide nanoparticles (Feridex) to characterize human HSC labeling to monitor the engraftment process. Conjugating fluorophores to the dextran coat for fluorescence-activated cell sorting purification eliminated spurious signals from nonsequestered nanoparticle contaminants. A short-term defined incubation strategy was developed that allowed efficient labeling of both quiescent and cycling HSC, with no discernable toxicity in vitro or in vivo. Transplantation of purified primary human cord blood lineage-depleted and CD34+ cells into immunodeficient mice allowed detection of labeled human HSC in the recipient bones. Flow cytometry was used to precisely quantitate the cell populations that had sequestered the nanoparticles and to follow their fate post-transplantation. Flow cytometry endpoint analysis confirmed the presence of nanoparticle-labeled human stem cells in the marrow. The use of fluorophore-labeled iron oxide nanoparticles for fluorescence imaging in combination with flow cytometry allows evaluation of labeling efficiencies and homing capabilities of defined human HSC subsets.",
keywords = "Feridex, Hematopoiesis, Human stem cells, Immune-deficient mice, Iron oxide, Nanoparticle, Transplantation",
author = "Maxwell, {Dustin J.} and Jesper Bonde and Hess, {David A.} and Hohm, {Sarah A.} and Ryan Lahey and Ping Zhou and Creer, {Michael H.} and David Piwnica-Worms and Jan Nolta",
year = "2008",
month = "2",
doi = "10.1634/stemcells.2007-0016",
language = "English (US)",
volume = "26",
pages = "517--524",
journal = "Stem Cells",
issn = "1066-5099",
publisher = "AlphaMed Press",
number = "2",

}

TY - JOUR

T1 - Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells

AU - Maxwell, Dustin J.

AU - Bonde, Jesper

AU - Hess, David A.

AU - Hohm, Sarah A.

AU - Lahey, Ryan

AU - Zhou, Ping

AU - Creer, Michael H.

AU - Piwnica-Worms, David

AU - Nolta, Jan

PY - 2008/2

Y1 - 2008/2

N2 - The use of nanometer-sized iron oxide particles combined with molecular imaging techniques enables dynamic studies of homing and trafficking of human hematopoietic stem cells (HSC). Identifying clinically applicable strategies for loading nanoparticles into primitive HSC requires strictly defined culture conditions to maintain viability without inducing terminal differentiation. In the current study, fluorescent molecules were covalently linked to dextran-coated iron oxide nanoparticles (Feridex) to characterize human HSC labeling to monitor the engraftment process. Conjugating fluorophores to the dextran coat for fluorescence-activated cell sorting purification eliminated spurious signals from nonsequestered nanoparticle contaminants. A short-term defined incubation strategy was developed that allowed efficient labeling of both quiescent and cycling HSC, with no discernable toxicity in vitro or in vivo. Transplantation of purified primary human cord blood lineage-depleted and CD34+ cells into immunodeficient mice allowed detection of labeled human HSC in the recipient bones. Flow cytometry was used to precisely quantitate the cell populations that had sequestered the nanoparticles and to follow their fate post-transplantation. Flow cytometry endpoint analysis confirmed the presence of nanoparticle-labeled human stem cells in the marrow. The use of fluorophore-labeled iron oxide nanoparticles for fluorescence imaging in combination with flow cytometry allows evaluation of labeling efficiencies and homing capabilities of defined human HSC subsets.

AB - The use of nanometer-sized iron oxide particles combined with molecular imaging techniques enables dynamic studies of homing and trafficking of human hematopoietic stem cells (HSC). Identifying clinically applicable strategies for loading nanoparticles into primitive HSC requires strictly defined culture conditions to maintain viability without inducing terminal differentiation. In the current study, fluorescent molecules were covalently linked to dextran-coated iron oxide nanoparticles (Feridex) to characterize human HSC labeling to monitor the engraftment process. Conjugating fluorophores to the dextran coat for fluorescence-activated cell sorting purification eliminated spurious signals from nonsequestered nanoparticle contaminants. A short-term defined incubation strategy was developed that allowed efficient labeling of both quiescent and cycling HSC, with no discernable toxicity in vitro or in vivo. Transplantation of purified primary human cord blood lineage-depleted and CD34+ cells into immunodeficient mice allowed detection of labeled human HSC in the recipient bones. Flow cytometry was used to precisely quantitate the cell populations that had sequestered the nanoparticles and to follow their fate post-transplantation. Flow cytometry endpoint analysis confirmed the presence of nanoparticle-labeled human stem cells in the marrow. The use of fluorophore-labeled iron oxide nanoparticles for fluorescence imaging in combination with flow cytometry allows evaluation of labeling efficiencies and homing capabilities of defined human HSC subsets.

KW - Feridex

KW - Hematopoiesis

KW - Human stem cells

KW - Immune-deficient mice

KW - Iron oxide

KW - Nanoparticle

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=40949124303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40949124303&partnerID=8YFLogxK

U2 - 10.1634/stemcells.2007-0016

DO - 10.1634/stemcells.2007-0016

M3 - Article

C2 - 18055451

AN - SCOPUS:40949124303

VL - 26

SP - 517

EP - 524

JO - Stem Cells

JF - Stem Cells

SN - 1066-5099

IS - 2

ER -